Dual inhibition of wound healing and oxidative process by montelukast in experimental colon anastomoses

Surg Innov. 2010 Sep;17(3):248-55. doi: 10.1177/1553350610376393. Epub 2010 Jul 15.

Abstract

Background: The authors aimed to investigate the effects of montelukast (ML) on the experimental rat colon anastomosis.

Methods: A total of 80 Wistar albino rats were divided into 4 groups: sham-operated, colon anastomosis, and colon anastomosis with oral administration (OAML) and rectal administration of 10 mg/kg/d ML (RAML). Anastomotic bursting pressure, anastomotic hydroxyproline contents, malondialdehyde (MDA), glutathione (GSH), glutathione peroxidase (GPX), and superoxide dismutase (SOD) levels, and the expressions of Ki-67, vascular endothelial growth factor (VEGF), and basic fibroblast growth factor (bFGF) with immunohistochemistry were assessed on postoperative day 5.

Results: Anastomotic bursting pressures and bFGF expressions were not changed, whereas tissue hydroxyproline concentrations and MDA levels and the expressions of Ki-67 and VEGF were significantly decreased, and GSH, GPX, and SOD levels were significantly increased in the OAML and RAML groups.

Conclusion: ML causes impairment of wound healing without altering the anastomosis bursting pressure and reverses the oxidative damage of the colon anastomoses in rats.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetates / administration & dosage*
  • Anastomosis, Surgical
  • Animals
  • Colon / drug effects
  • Colon / surgery*
  • Cyclopropanes
  • Disease Models, Animal
  • Leukotriene Antagonists / administration & dosage*
  • Oxidative Stress / drug effects*
  • Quinolines / administration & dosage*
  • Rats
  • Rats, Wistar
  • Sulfides
  • Treatment Outcome
  • Wound Healing / drug effects*

Substances

  • Acetates
  • Cyclopropanes
  • Leukotriene Antagonists
  • Quinolines
  • Sulfides
  • montelukast